http://www.unboundmedicine.com/medline/ebm/research/risperidoneUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19890258/full_citation/Early_Response_to_Antipsychotic_Drug_Therapy_as_a_Clinical_Marker_of_Subsequent_Response_in_the_Treatment_of_Schizophrenia_Kinon BJ, Chen L, Ascher-Svanum H, et al. 
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia. [JOURNAL ARTICLE]
Neuropsychopharmacology 2009 Nov 4.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886879/full_citation/Paliperidone_palmitate___review_of_the_efficacy_safety_and_cost_of_a_new_second_generation_depot_antipsychotic_medication_Citrome L 
Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication. [JOURNAL ARTICLE]
Int J Clin Pract 2009 Nov 3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19881277/full_citation/Effects_of_Formulation_Parameters_on_Encapsulation_Efficiency_and_Release_Behavior_of_Risperidone_Poly_DL_lactide_co_glycolide__Microsphere_Su Z, Sun F, Shi Y, et al. 
Effects of Formulation Parameters on Encapsulation Efficiency and Release Behavior of Risperidone Poly(D,L-lactide-co-glycolide) Microsphere. [Journal Article]
Chem Pharm Bull (Tokyo) 2009 Nov; 57(11):1251-6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19877982/full_citation/A_naturalistic_study_of_predictors_and_risks_of_atypical_antipsychotic_use_in_an_attention_deficit/hyperactivity_disorder_clinic_Weiss M, Panagiotopoulos C, Giles L, et al. 
A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic. [Journal Article, Research Support, Non-U.S. Gov't]
J Child Adolesc Psychopharmacol 2009 Oct; 19(5):575-82.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19877981/full_citation/Lack_of_effect_of_stimulant_combination_with_second_generation_antipsychotics_on_weight_gain_metabolic_changes_prolactin_levels_and_sedation_in_youth_with_clinically_relevant_aggression_or_oppositionality_Penzner JB, Dudas M, Saito E, et al. 
Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
J Child Adolesc Psychopharmacol 2009 Oct; 19(5):563-73.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19875272/full_citation/Effects_of_repeated_risperidone_exposure_on_serotonin_receptor_subtypes_in_developing_rats_Choi YK, Moran-Gates T, Gardner MP, et al. 
Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. [JOURNAL ARTICLE]
Eur Neuropsychopharmacol 2009 Oct 28.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19873684/full_citation/Leptin_gene__2548G/A_variants_predict_risperidone_associated_weight_gain_in_children_and_adolescents_Calarge CA, Ellingrod VL, Zimmerman B, et al. 
Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents. [Journal Article, Research Support, N.I.H., Extramural]
Psychiatr Genet 2009 Dec; 19(6):320-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19864614/full_citation/Attenuation_of_phencyclidine_induced_object_recognition_deficits_by_the_combination_of_atypical_antipsychotic_drugs_with_pimavanserin__ACP_103__a_5_hydroxytryptamine2A_receptor_inverse_agonist_Snigdha S, Horiguchi M, Li Z, et al. 
Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs with pimavanserin (ACP 103), a 5-hydroxytryptamine2A receptor inverse agonist. [JOURNAL ARTICLE]
J Pharmacol Exp Ther 2009 Oct 28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19864585/full_citation/Effects_of_the_antipsychotic_risperidone_on_dopamine_synthesis_in_human_brain_measured_by_positron_emission_tomography_with_L_[beta_11C]DOPA:_a_stabilizing_effect_for_dopaminergic_neurotransmissionIto H, Takano H, Takahashi H, et al. 
Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission? [Journal Article, Research Support, Non-U.S. Gov't]
J Neurosci 2009 Oct 28; 29(43):13730-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19864114/full_citation/Impact_of_antipsychotic_medication_on_family_burden_in_schizophrenia:_Longitudinal_results_of_CATIE_trial_Perlick DA, Rosenheck RA, Kaczynski R, et al. 
Impact of antipsychotic medication on family burden in schizophrenia: Longitudinal results of CATIE trial. [JOURNAL ARTICLE]
Schizophr Res 2009 Oct 27.
Abstract | Full Citation | Find Related Articles